Natural product immunomodulator

1 marketed 1 in Phase 3

This page covers all Natural product immunomodulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Phospholipase A2, melittin, multiple immune cell receptors.

Targets

Phospholipase A2, melittin, multiple immune cell receptors

Marketed (1)

Phase 3 pipeline (1)